Clinical Data Affirms Dupilumab for Chronic Nasal Polyps
Provisional 'real-life' data showed dupilumab improved outcomes for challenging patients with chronic rhinosinusitis and nasal polyps.
Source: medscape.com
Stay updated with breaking news from Seongh Cho. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Provisional 'real-life' data showed dupilumab improved outcomes for challenging patients with chronic rhinosinusitis and nasal polyps.
/PRNewswire/ -- Optinose (NASDAQ:OPTN), a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat...